View of Roghan Mālish ‘A Topical Formulation’ Attenuates Joint Pain, Down-Regulates C-Reactive Protein Level and Improves Quality of Life in Patients with Waja‘ al-Mafāṣil (NUMC: L-4) (Arthralgia) – A Pilot Clinical Study

Return to Article Details Roghan Mālish ‘A Topical Formulation’ Attenuates Joint Pain, Down-Regulates C-Reactive Protein Level and Improves Quality of Life in Patients with Waja‘ al-Mafāṣil (NUMC: L-4) (Arthralgia) – A Pilot Clinical Study Download Download PDF